TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A study published in Neurology found that adults 65 and older who received a high-dose flu vaccine had a lower observed risk of Alzheimer’s disease than those who received a standard-dose vaccine. The reported risk reduction was nearly 55% for high-dose vaccination and 40% for standard-dose vaccination, but the study shows an association, not proof that the vaccine prevents Alzheimer’s.
A study of nearly 200,000 adults aged 65 and older found that recipients of a high-dose flu vaccine had a lower observed risk of developing Alzheimer’s disease than recipients of a standard-dose shot, according to research led by UTHealth Houston and published in the journal Neurology. The researchers reported an association of nearly 55% lower risk for high-dose vaccination, but the findings do not establish that the vaccine prevents Alzheimer’s.
The analysis compared older adults who received high-dose or standard-dose influenza vaccines. The researchers reported that standard-dose vaccination was associated with a 40% reduction in Alzheimer’s risk, while the high-dose formulation was associated with a reduction of nearly 55%, a finding relevant to other research on factors linked to dementia risk. The supplied report does not specify the comparison baseline for those percentages, so they should not be read as a direct estimate of the benefit of high-dose vaccination over standard-dose vaccination.
The association appeared stronger among women, the report said, though it did not provide a sex-specific percentage or further detail about that analysis. The study’s senior author, Paul Schulz, is a professor of neurology at McGovern Medical School at UTHealth Houston and directs its Neurocognitive Disorders Center.
The research examined vaccine records and Alzheimer’s outcomes among people over 65, an age group at increased risk of the disease, as have studies exploring other associations with dementia risk. The source report describes the study as an analysis of existing data; it does not say participants were randomly assigned to vaccine doses. That distinction matters because differences between people receiving each formulation could contribute to the observed results.
What the Dose Difference Could Mean
The results add a dose-specific finding to prior research linking flu vaccination with lower Alzheimer’s risk. They may be relevant to older adults and public health planners because high-dose vaccines are already used to address the weaker immune response that can come with age. However, the study does not show that choosing a high-dose shot will reduce an individual’s chance of developing dementia by a particular amount.
Alzheimer’s disease is the leading cause of dementia. The report says that in 2025, more than 7 million Americans aged 65 and older were living with the disease, or about one in nine people in that age group. Researchers’ interest in possible links between vaccination and brain health therefore concerns a substantial public health burden, but the findings need careful interpretation before they can support conclusions about prevention.
High-dose influenza vaccines contain four times as much influenza antigen as standard-dose shots, according to the source report. The higher amount is intended to prompt a stronger immune response in older adults. The study raises the possibility that vaccine formulation could be relevant to outcomes beyond influenza, but it does not identify a biological mechanism explaining the Alzheimer’s association.
Products Worth Considering
Therabody Theragun Relief Massage Gun, 3-Speed, Black
Garmin Forerunner 570 GPS Running Smartwatch, 42 mm, Raspberry, with P-Bank Bundle
Oral-B iO5 Rechargeable Electric Toothbrush with 5 Cleaning Modes and Travel Case, White
As an affiliate, we earn on qualifying purchases.
From Earlier Vaccine Findings to Dose
The new analysis follows a 2022 study led by Schulz’s team that found influenza vaccination was associated with reduced Alzheimer’s risk among adults 65 and older. The later investigation asked whether risk differed by vaccine dose, after public health officials raised that question during a discussion of the earlier findings.
Schulz said the question came from public health officials who had reviewed the team’s prior research. “The public health department had seen our vaccine research and asked if I could come down to talk to them about it,” he said. “We went through the findings, and they asked if there was a difference with different dosages; I was confused.”
The Centers for Disease Control and Prevention recommends a high-dose flu vaccine as a preferred option for adults aged 65 and older, according to the source material. Before 2022, federal guidance did not express a preference among injectable flu vaccine types for this age group. The report also notes that high-dose supply can sometimes fall short of demand, leading some older adults to receive standard-dose shots.
““The public health department had seen our vaccine research and asked if I could come down to talk to them about it.””
— Paul Schulz, senior author and UTHealth Houston neurology professor
What the Study Cannot Establish
The reported finding is an association, not evidence that a high-dose flu shot caused lower Alzheimer’s risk. The supplied material does not give enough information about study design, follow-up duration, statistical methods, or how researchers accounted for differences between vaccine recipients. Those details are needed to judge how strongly other factors might explain the result.
The report also does not state the exact comparison group used to calculate the 40% and nearly 55% reductions, or provide confidence intervals and absolute risk figures. The percentages therefore should not be interpreted as a direct 15-percentage-point advantage for high-dose over standard-dose vaccination. The reported stronger association among women also lacks a specific estimate in the source material.
Researchers have not established a mechanism connecting vaccine dose with Alzheimer’s risk, and the findings do not show that vaccination can prevent or treat the disease. It remains unclear whether further research will reproduce the association or clarify whether it reflects an effect of vaccination, differences among the people vaccinated, or other factors.
Further Research on Dose and Risk
The study adds a dose comparison to a line of observational research, but the next step is for other researchers to examine whether the association holds in additional populations and with more detailed analyses. Further work could also clarify the study’s comparison baseline, account for potential differences between recipients, and test why the reported association appeared stronger among women.
For now, the study does not change the distinction between influenza vaccination guidance and Alzheimer’s prevention: the source material describes high-dose shots as a preferred flu vaccine option for adults aged 65 and older, not as an Alzheimer’s intervention. Any decisions about vaccination should follow current public health guidance and advice from a qualified health professional. No additional study or follow-up timetable is specified in the supplied report.
Key Questions
Does the study prove that a high-dose flu shot prevents Alzheimer’s?
No. The researchers reported an association between high-dose vaccination and lower observed Alzheimer’s risk. The findings do not establish that the vaccine caused the difference or prevents the disease.
How large was the reported association?
The report says standard-dose vaccination was associated with a 40% reduction in risk and high-dose vaccination with a reduction of nearly 55%. It does not provide the comparison baseline in the supplied material, so those figures should not be treated as a direct comparison between the two doses.
Who was included in the study?
The researchers analyzed data from nearly 200,000 men and women aged 65 and older. The source report does not provide further details on the participants or the length of follow-up.
Why are high-dose flu shots offered to older adults?
The source report says high-dose vaccines contain four times as much influenza antigen as standard-dose shots and are intended to prompt a stronger immune response in older adults. The report describes the CDC as recommending them as a preferred option for people aged 65 and older.
Did women have a different result?
The report says the association was more pronounced among women, but it does not give a specific percentage or enough detail to assess that finding independently.
Source: sciencedaily.com
